-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €57.95 Price Target at Berenberg Bank
Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €57.95 Price Target at Berenberg Bank
Berenberg Bank set a €57.95 ($59.13) price target on Fresenius Medical Care AG & Co. KGaA (ETR:FME – Get Rating) in a report issued on Monday, Borsen Zeitung reports.
Other research analysts have also issued research reports about the company. Deutsche Bank Aktiengesellschaft set a €37.00 ($37.76) price objective on Fresenius Medical Care AG & Co. KGaA in a report on Tuesday, August 2nd. Warburg Research set a €42.00 ($42.86) price objective on Fresenius Medical Care AG & Co. KGaA in a report on Friday. Barclays set a €40.00 ($40.82) price objective on Fresenius Medical Care AG & Co. KGaA in a report on Friday. Jefferies Financial Group set a €64.00 ($65.31) price objective on Fresenius Medical Care AG & Co. KGaA in a report on Monday, July 25th. Finally, JPMorgan Chase & Co. set a €23.00 ($23.47) price objective on Fresenius Medical Care AG & Co. KGaA in a report on Friday, July 29th.
Get Fresenius Medical Care AG & Co. KGaA alerts:Fresenius Medical Care AG & Co. KGaA Stock Performance
Shares of FME stock opened at €36.79 ($37.54) on Monday. The company has a market capitalization of $10.79 billion and a P/E ratio of 13.18. The business's 50 day moving average is €46.85 and its two-hundred day moving average is €54.81. The company has a current ratio of 1.18, a quick ratio of 0.70 and a debt-to-equity ratio of 88.41. Fresenius Medical Care AG & Co. KGaA has a 12-month low of €35.08 ($35.80) and a 12-month high of €69.96 ($71.39).
Fresenius Medical Care AG & Co. KGaA Company Profile
(Get Rating)Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
See Also
- Home Depot, Lowe's On Track To Grow 2022 Earnings
- Could Smaller be Better for Investors in Norwegian Cruise Lines?
- Walmart Or Target: Which Is The Stronger Stock?
- Volume Surges Spark Turnarounds for These 3 Stocks
- Can Etsy Continue to Thrive After the Pandemic?
Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
Berenberg Bank set a €57.95 ($59.13) price target on Fresenius Medical Care AG & Co. KGaA (ETR:FME – Get Rating) in a report issued on Monday, Borsen Zeitung reports.
據Borsen Zeitung報道,貝倫伯格銀行在週一發佈的一份報告中為Fresenius Medical Care AG&Co.KGaA(ETR:FME-GET評級)設定了57.95歐元(59.13美元)的目標價。
Other research analysts have also issued research reports about the company. Deutsche Bank Aktiengesellschaft set a €37.00 ($37.76) price objective on Fresenius Medical Care AG & Co. KGaA in a report on Tuesday, August 2nd. Warburg Research set a €42.00 ($42.86) price objective on Fresenius Medical Care AG & Co. KGaA in a report on Friday. Barclays set a €40.00 ($40.82) price objective on Fresenius Medical Care AG & Co. KGaA in a report on Friday. Jefferies Financial Group set a €64.00 ($65.31) price objective on Fresenius Medical Care AG & Co. KGaA in a report on Monday, July 25th. Finally, JPMorgan Chase & Co. set a €23.00 ($23.47) price objective on Fresenius Medical Care AG & Co. KGaA in a report on Friday, July 29th.
其他研究分析師也發佈了關於該公司的研究報告。德意志銀行Aktiengesellschaft在8月2日週二的一份報告中為Fresenius Medical Care AG&Co.KGaA設定了37.00歐元(37.76美元)的目標價格。Warburg Research在週五的一份報告中為費森尤斯醫療保健公司(Fresenius Medical Care AG&Co.KGaA)設定了42.00歐元(合42.86美元)的目標價格。巴克萊在週五的一份報告中為費森尤斯醫療保健公司(Fresenius Medical Care AG&Co.KGaA)設定了40.00歐元(合40.82美元)的目標價。傑富瑞金融集團在7月25日星期一的一份報告中為Fresenius Medical Care AG&Co.KGaA設定了64.00歐元(65.31美元)的價格目標。最後,摩根大通在7月29日週五的一份報告中為費森尤斯醫療保健公司設定了23.00歐元(23.47美元)的目標價格。
Fresenius Medical Care AG & Co. KGaA Stock Performance
費森尤斯醫療保健股份公司KGaA股票表現
Shares of FME stock opened at €36.79 ($37.54) on Monday. The company has a market capitalization of $10.79 billion and a P/E ratio of 13.18. The business's 50 day moving average is €46.85 and its two-hundred day moving average is €54.81. The company has a current ratio of 1.18, a quick ratio of 0.70 and a debt-to-equity ratio of 88.41. Fresenius Medical Care AG & Co. KGaA has a 12-month low of €35.08 ($35.80) and a 12-month high of €69.96 ($71.39).
FME股票週一開盤報36.79歐元(合37.54美元)。該公司市值為107.9億美元,市盈率為13.18倍。該業務的50日移動均線切入位在46.85歐元,200日移動均線切入位在54.81歐元。該公司的流動比率為1.18,速動比率為0.70,債務權益比率為88.41。Fresenius Medical Care AG&Co.KGaA的股價跌至35.08歐元(合35.80美元)的12個月低點,以及69.96歐元(合71.39美元)的12個月高位。
Fresenius Medical Care AG & Co. KGaA Company Profile
費森尤斯醫療保健股份公司簡介
Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Fresenius Medical Care AG&Co KGaA在德國、北美和國際上提供透析護理和相關的透析護理服務。它通過門診透析診所網絡提供透析治療以及相關的實驗室和診斷服務;材料、培訓和患者支持服務,包括臨牀監測、後續援助和安排將用品運送到患者住所;以及根據合同向美國醫院提供為住院的終末期腎病(ESRD)患者和急性腎功能衰竭患者提供的透析服務。
See Also
另請參閲
- Home Depot, Lowe's On Track To Grow 2022 Earnings
- Could Smaller be Better for Investors in Norwegian Cruise Lines?
- Walmart Or Target: Which Is The Stronger Stock?
- Volume Surges Spark Turnarounds for These 3 Stocks
- Can Etsy Continue to Thrive After the Pandemic?
- 家得寶,Lowe‘s有望在2022年實現收益增長
- 對挪威郵輪公司的投資者來説,更小的規模會更好嗎?
- 沃爾瑪和塔吉特:哪隻股票更強?
- 這3只股票成交量飆升,火花回升
- 在大流行之後,Etsy能否繼續蓬勃發展?
Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
接受Fresenius Medical Care AG&Co.KGaA Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Fresenius Medical Care AG&Co.KGaA和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧